Table 4. Ratio of immune response after LPS stimulation and 28-day mortality a.
All (N = 75) Median (IQR) |
Non-survivors (n = 14) Median (IQR) |
Survivors (n = 61) Median (IQR) |
P value |
|
---|---|---|---|---|
G-CSF | 2.06 (3.85) | 3.70 (4.99) | 2.01 (2.87) | 0.230 |
IL-10 | 1.60 (0.78) | 1.42 (1.17) | 1.65 (0.73) | 0.669 |
IL-6 | 2.68 (2.69) | 4.60 (5.98) | 2.62 (1.70) | 0.017 |
TNF-α | 2.09 (1.95) | 2.85 (4.56) | 2.05 (1.55) | 0.027 |
a Kruskal-Wallis test was used for assessing the association between post LPS stimulation immune response and immune dysfunction score.
G-CSF, granulocyte-colony stimulating factor; LPS, lipopolysaccharide; IL, interleukin; TNF-α, tumor necrosis factor-α